UK regulators approve injectable form of nivolumab for solid tumours
The Medicines and Healthcare products Regulatory Agency (MHRA) in the [...]
Immunotherapy for the treatment of non-clear cell kidney cancer
There are several types of kidney cancer, the most common [...]
IKCC Global Kidney Cancer Summit
Julia Black, Karen McNee and Steve Pointon represented UK kidney [...]
Europe has approved subcutaneous nivolumab for solid tumours
The Committee for Medicinal Products for Human Use (CHMP) of [...]
